tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BMEA Stock Latest News

Biomea Fusion price target lowered to $18 from $40 at H.C. Wainwright
The FlyBiomea Fusion price target lowered to $18 from $40 at H.C. Wainwright
7d ago
BMEA
Biomea Fusion reports Q1 EPS (80c), consensus (60c)
PremiumThe Fly
Biomea Fusion reports Q1 EPS (80c), consensus (60c)
8d ago
BMEA
Biomea Fusion price target lowered to $3 from $11 at Barclays
PremiumThe Fly
Biomea Fusion price target lowered to $3 from $11 at Barclays
1M ago
BMEA
Biomea Fusion’s Strategic Shift: A Year of Transformation
PremiumCompany Announcements
Biomea Fusion’s Strategic Shift: A Year of Transformation
1M ago
BMEA
Biomea Fusion reports Q4 EPS (81c), consensus (93c)
PremiumThe Fly
Biomea Fusion reports Q4 EPS (81c), consensus (93c)
1M ago
BMEA
Buy Rating for Biomea Fusion’s Icovamenib: A Promising Breakthrough in Diabetes Treatment
PremiumRatingsBuy Rating for Biomea Fusion’s Icovamenib: A Promising Breakthrough in Diabetes Treatment
1M ago
BMEA
Biomea Fusion Appoints Interim CEO Amid Leadership Changes
Premium
Company Announcements
Biomea Fusion Appoints Interim CEO Amid Leadership Changes
2M ago
8K
BMEA
Biomea Fusion names Mick Hitchcock to succeed Thomas Butler as interim CEO
Premium
The Fly
Biomea Fusion names Mick Hitchcock to succeed Thomas Butler as interim CEO
2M ago
BMEA
Biomea Fusion price target lowered to $10 from $50 at Oppenheimer
PremiumThe Fly
Biomea Fusion price target lowered to $10 from $50 at Oppenheimer
2M ago
BMEA
Promising Potential of Biomea Fusion’s Icovamenib Justifies Buy Rating
PremiumRatings
Promising Potential of Biomea Fusion’s Icovamenib Justifies Buy Rating
2M ago
BMEA
Biomea Fusion announces presentation of icovamenib preclinical, clinical data
PremiumThe Fly
Biomea Fusion announces presentation of icovamenib preclinical, clinical data
2M ago
BMEA
Biomea Fusion reports inducement grant under Nasdaq listing rule
PremiumThe Fly
Biomea Fusion reports inducement grant under Nasdaq listing rule
2M ago
BMEA
Is BMEA a Buy, Before Earnings?
PremiumPre-EarningsIs BMEA a Buy, Before Earnings?
2M ago
BMEA
Biomea Fusion CFO Franco Valle Resigns
Premium
Company Announcements
Biomea Fusion CFO Franco Valle Resigns
2M ago
8K
BMEA
Biomea Fusion to unveil ew icovamenib data at ATTD 2025
Premium
The Fly
Biomea Fusion to unveil ew icovamenib data at ATTD 2025
2M ago
BMEA
Biomea Fusion price target lowered to $16 from $128 at D. Boral Capital
PremiumThe Fly
Biomea Fusion price target lowered to $16 from $128 at D. Boral Capital
4M ago
BMEA
Biomea Fusion to become diabetes, obesity medicines company
PremiumThe Fly
Biomea Fusion to become diabetes, obesity medicines company
4M ago
BMEA
Biomea Fusion reports new preclinical data on icovamenib-semaglutide study
PremiumThe Fly
Biomea Fusion reports new preclinical data on icovamenib-semaglutide study
4M ago
BMEA
Biomea Fusion Advances Diabetes Treatment with Positive Study Results
PremiumCompany Announcements
Biomea Fusion Advances Diabetes Treatment with Positive Study Results
5M ago
8K
BMEA
Biomea’s icovamenib meets HbA1c standards in T2D, says H.C. Wainwright
PremiumThe FlyBiomea’s icovamenib meets HbA1c standards in T2D, says H.C. Wainwright
5M ago
BMEA
Biomea Fusion price target lowered to $50 from $60 at Oppenheimer
Premium
The Fly
Biomea Fusion price target lowered to $50 from $60 at Oppenheimer
5M ago
BMEA
Biomea Fusion announces results from ongoing COVALENT-111 study
Premium
The Fly
Biomea Fusion announces results from ongoing COVALENT-111 study
5M ago
BMEA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >